These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Introduction of trimethoprim: a mixed blessing.
    Author: Gleckman RA.
    Journal: Urology; 1981 May; 17(5):460-1. PubMed ID: 7233660.
    Abstract:
    Trimethoprim recently has been released by the Food and Drug Administration (FDA) exclusively for the treatment of acute symptomatic uncomplicated bacterial urinary tract infections. The compound compares favorably with alternative standard agents, such as ampicillin and cephalexin, for the therapy of women with acute symptomatic urinary tract infections caused by Escherichia coli. Trimethoprim should not be prescribed for the pregnant woman. Indiscriminate administration of the drug could foster the emergence of strains resistant to trimethoprim and trimethoprim-sulfamethoxazole. Trimethoprim has not been approved by the FDA for the treatment of recurrent, bacterial urinary tract infections.
    [Abstract] [Full Text] [Related] [New Search]